background
glycyrrhizin
ga
primari
metabolit
acid
gra
pharmacolog
activ
compon
medicin
licoric
root
shown
antivir
immunomodulatori
properti
although
properti
well
establish
mechan
action
complet
understood
studi
ga
gra
test
abil
inhibit
rotaviru
replic
cell
cultur
toward
long
term
goal
discov
natur
compound
may
complement
exist
vaccin
method
epitheli
cell
treat
ga
gra
variou
time
preor
postinfect
viru
yield
measur
immunofluoresc
focu
assay
level
viral
protein
gra
treat
cell
measur
immunoblot
determin
effect
gra
treatment
accumul
viral
protein
result
gra
treatment
reduc
rotaviru
yield
ad
infect
cultur
postviru
adsorpt
wherea
viru
yield
ga
treat
cultur
similar
mock
treat
control
time
addit
experi
indic
gramedi
replic
inhibit
like
occur
step
step
subsequ
viru
entri
amount
substanti
reduc
gra
ad
cultur
two
hour
postentri
conclus
gra
ga
signific
antivir
activ
rotaviru
replic
vitro
studi
determin
whether
gra
attenu
rotaviru
replic
vivo
underway
rotavirus
preval
caus
acut
viral
gastroenter
children
less
five
year
age
recent
estim
indic
million
case
occur
year
us
death
occur
annual
worldwid
review
avail
data
two
attenu
vaccin
show
efficaci
reduc
incid
sever
rotaviru
gastroenter
us
develop
countri
report
vaccin
efficaci
lower
develop
nation
major
death
rotaviru
infect
occur
like
due
multipl
factor
includ
suboptim
immun
respons
associ
poor
nutrit
statu
concurr
enter
infect
method
enhanc
natur
diseas
resist
find
valu
region
protect
immun
could
improv
complement
exist
vaccin
product
antivir
immun
adjuv
activ
licoric
deriv
root
perenni
herb
glycyrrhiza
spp
addit
use
sweeten
agent
one
extens
use
medicin
plant
pharmacolog
activ
compon
studi
includ
triterpen
saponin
glycyrrhizin
ga
present
highest
concentr
acid
gra
aglycon
product
ga
hydrolysi
mediat
gut
bacteri
glucoronidas
ga
gra
studi
sever
system
evalu
immunomodulatori
properti
ga
use
japan
year
treat
chronic
viral
hepat
patient
administ
continu
regimen
intraven
formul
ga
stronger
neominophagen
c
w
snmc
demonstr
clinic
improv
reduc
incid
hepatocellular
carcinoma
ga
also
studi
anim
model
viral
infect
mice
administ
ga
intraperiton
surviv
lethal
dose
influenza
viru
antibodi
abolish
protect
effect
mechan
protect
model
system
remain
unclear
mechan
action
vivo
well
understood
like
multifactori
could
due
direct
effect
viru
replic
function
associ
modul
inflammatori
cell
protect
respons
initi
report
describ
antivir
activ
ga
vitro
show
reduc
replic
vesicular
stomat
viru
vsv
vaccinia
viru
vv
herp
simplex
viru
newcastl
diseas
viru
ndv
polioviru
type
subsequ
ga
shown
antivir
activ
virus
sever
famili
includ
flavivirus
herpesvirus
influenza
viru
sar
coronaviru
hepat
c
viru
other
review
suggest
mechan
activ
system
includ
direct
effect
adsorpt
penetr
particl
matur
step
replic
cycl
case
direct
inactiv
viru
particl
exampl
antiinfluenza
viru
activ
ga
cell
cultur
attribut
interfer
viral
endocytosi
like
due
abil
modul
membran
fluiditi
although
altern
mechan
recent
propos
gra
antitumorigen
antiulc
antiinflammatori
antihepatotox
activ
vitro
vivo
util
gra
antivir
compound
well
describ
ga
data
suggest
gra
immunomodulatori
cell
protect
activ
vitro
vivo
exampl
vitro
gra
induc
nitric
oxid
synthas
express
macrophag
express
epitheli
cell
other
studi
also
suggest
potenti
antiinflammatori
activ
associ
reduc
cytokin
express
attenu
activ
vivo
protect
efficaci
gra
protozoan
bacteri
infect
demonstr
mous
model
viscer
leishmaniasi
analysi
proinflammatori
cytokin
transcript
isol
spleen
cell
infect
anim
reveal
gra
induc
indic
h
cur
respons
bacteri
system
gra
attenu
lung
patholog
associ
staphyloccu
aureu
pneumonia
rel
lack
data
regard
specif
antivir
activ
gra
compar
ga
led
us
expand
previou
data
show
gra
treatment
reduc
rotaviru
replic
cell
cultur
includ
ga
analys
given
wealth
data
avail
compound
current
avail
clinic
use
show
gra
treatment
result
signific
reduct
rotaviru
titer
ad
cultur
postinfect
level
viral
structur
protein
nonstructur
protein
reduc
gra
treat
cell
consist
antirotaviru
activ
compound
shown
gra
toxic
cell
highest
concentr
test
perform
extend
titrat
studi
includ
ga
cytotox
cell
previous
test
cell
treat
serial
dilut
ga
gra
cytotox
measur
follow
six
hour
incub
data
shown
figur
indic
concentr
ml
gra
show
approxim
reduct
cell
viabil
respect
time
point
extens
incub
past
hour
result
signific
cytotox
data
shown
contrast
gra
ga
cytotox
highest
concentr
test
mgml
compound
use
remaind
experi
final
concentr
gra
reduc
rotaviru
infect
ga
effect
previou
time
cours
effect
gra
rotaviru
replic
show
approxim
reduct
infect
bovin
rotaviru
strain
ncdv
cell
treat
six
hour
prior
infect
prior
experi
measur
replic
low
multipl
infect
pfucel
long
cours
infect
measur
cellassoci
viru
current
experi
design
measur
one
round
replic
higher
multipl
infect
three
pfucel
could
begin
deciph
mechan
inhibit
includ
celltocel
spread
test
inhibitori
effect
ga
gra
rotaviru
infect
compound
ad
cell
either
six
hour
prior
rrv
infect
follow
adsorpt
step
cultur
harvest
six
hour
postinfect
infecti
viru
titer
ifa
contrast
previou
studi
use
low
multipl
infect
pretreat
significantli
reduc
viru
titer
condit
experi
figur
contrast
gra
treatment
result
reduct
infect
compound
continu
present
prepost
ad
postinfect
post
level
reduct
viru
yield
explain
simpl
cytotox
effect
cell
degre
defin
toxic
assay
ga
effect
viru
yield
whether
compound
ad
preor
postinfect
titer
differ
significantli
mock
treat
infect
control
therefor
ga
investig
gra
reduc
infect
direct
effect
viru
particl
gra
reduc
rotaviru
infect
ad
cultur
follow
adsorpt
step
determin
direct
effect
gra
viru
particl
rrv
stock
mix
gra
dmso
incub
one
hour
viru
suspens
concentr
ultracentrifug
infect
measur
ifa
data
shown
figur
illustr
infect
reduc
stock
viru
treat
gra
prior
inocul
suggest
abil
gra
inhibit
replic
result
direct
detriment
effect
viru
particl
gra
reduc
infect
postentri
step
gra
inhibitori
rrv
replic
ad
cultur
postviru
adsorpt
determin
whether
reduct
titer
observ
cell
treat
gra
result
block
viru
entri
cell
inocul
rrv
multipl
infect
three
pfucel
viru
adsorb
one
hour
incub
allow
viru
adsorpt
entri
cell
adsorpt
period
cultur
incub
one
hour
allow
viru
entri
gra
dmso
ad
infect
allow
proceed
five
hour
result
show
infecti
viru
titer
reduc
gra
ad
follow
incub
figur
suggest
gra
inhibit
rrv
replic
step
subsequ
viru
entri
cell
begin
understand
gra
inhibit
replic
level
viral
protein
gra
treat
cell
examin
rrv
adsorb
monolay
one
hour
adsorpt
medium
remov
replac
fresh
medium
cultur
incub
one
hour
allow
viru
entri
gra
ad
cultur
infect
allow
proceed
five
hour
lysat
prepar
subject
immunoblot
figur
show
substanti
reduct
amount
gra
treat
cell
evid
viru
replic
occur
measur
time
point
provid
detect
level
also
significantli
reduc
treat
cell
compar
untreat
cell
assess
reduct
amount
treat
cell
experi
perform
except
gra
ad
two
hour
follow
incub
result
indic
degre
reduct
similar
previou
experi
figur
amount
still
diminish
howev
higher
observ
gra
ad
one
hour
follow
incub
one
interpret
result
suggest
addit
gra
later
time
postadsorpt
may
diminish
effect
level
viral
protein
consequ
viru
titer
observ
level
remain
low
suggest
mechan
play
togeth
data
show
gra
profound
effect
accumul
rotaviru
protein
infect
cell
consist
observ
reduct
yield
infecti
viru
antivir
properti
two
princip
pharmacolog
activ
constitu
licoric
root
ga
gra
extens
describ
far
data
avail
ga
mechan
compound
antivir
step
viru
replic
cycl
act
vari
depend
viru
b
figur
gra
inactiv
rotaviru
particl
inhibit
replic
postentri
rrv
stock
incub
gra
dmso
one
hour
viru
concentr
ultracentrifug
two
hour
rpm
rotor
beckman
infect
measur
ifa
data
triplic
sampl
p
b
trypsinactiv
rrv
inocul
onto
cell
multipl
infect
pfucel
adsorb
one
hour
follow
adsorpt
medium
replac
cultur
incub
one
hour
allow
viru
entri
gra
dmso
ad
cultur
follow
incub
viru
titer
follow
addit
hour
infect
determin
ifa
data
analyz
signific
twotail
student
test
error
bar
indic
sem
p
investig
ampl
data
suggest
antivir
activ
ga
vivo
may
result
induct
cytoprotect
immunomodulatori
respons
rather
effect
virusspecif
function
per
se
mechan
action
could
part
explain
broadspectrum
activ
review
contrast
ga
fewer
report
vivo
activ
gra
avail
howev
administ
intraven
ga
metabol
liver
lysosom
acid
final
glucoronidas
intestin
bacteria
gra
reabsorb
therefor
possibl
vivo
effect
ga
due
one
metabolit
includ
gra
shown
gra
reduc
rotaviru
yield
singl
round
replic
cell
wherea
ga
given
numer
report
antivir
activ
ga
vitro
somewhat
surpris
ga
effect
rotaviru
replic
howev
inhibitori
activ
ga
may
prefer
envelop
virus
consist
potenti
mechan
action
attribut
effect
membran
fluiditi
gra
directli
inactiv
rotaviru
particl
yield
infecti
viru
reduc
viru
stock
incub
compound
prior
inocul
onto
cell
reduct
yield
infecti
viru
viral
protein
level
gra
ad
cultur
two
hour
postadsorpt
suggest
interfer
rotaviru
replic
occur
step
subsequ
viru
entri
data
consist
previou
studi
illustr
similar
effect
ga
vitro
replic
ndv
vsv
vv
compound
ad
sever
hour
postinfect
interestingli
amount
present
gra
ad
twohour
postentri
similar
level
observ
gra
ad
one
hour
postentri
amount
consider
higher
observ
could
explain
effect
viral
transcript
translat
degrad
viral
protein
mechan
would
explain
select
reduct
difficult
predict
studi
conclus
defin
step
gra
exert
inhibitori
effect
progress
multipl
mechan
gra
could
reduc
viru
yield
includ
effect
specif
step
replic
cycl
cellular
pathway
play
role
establish
environ
conduc
maximum
replic
effici
exampl
shown
gra
induc
activ
cell
recent
report
rotaviru
strain
downregul
activ
function
nonstructur
protein
activ
requir
induct
robust
antivir
respons
sustain
activ
gra
could
overrid
virusencod
mechan
downregul
activ
result
reduc
viru
replic
studi
also
report
gramedi
activ
note
howev
report
show
gra
inhibit
activ
interpret
gramedi
regul
inflammatori
respons
studi
effect
gra
measur
follow
induct
pathway
viru
infect
proinflammatori
mediat
suggest
effect
gra
contextdepend
deciph
interact
gra
signal
pathway
molecular
level
contribut
understand
activ
modul
depend
stimulu
one
possibl
altern
mechan
replic
inhibit
mutual
exclus
provid
sever
report
indic
gra
modul
activ
pharmacolog
inhibit
pathway
substanti
reduc
rotaviru
yield
cultur
effect
gra
signal
pathway
context
rotaviru
infect
gra
may
modul
current
investig
togeth
data
report
show
gra
inhibit
rotaviru
replic
step
step
subsequ
viru
entri
support
antivir
activ
gra
report
system
rotaviru
infect
matur
enterocyt
villu
tip
proxim
small
intestin
thu
vivo
tropism
polar
epitheli
cell
continu
studi
address
whether
differ
either
gra
toxic
level
reduct
viru
replic
cell
type
administ
gra
concentr
mgkg
mice
observ
clinic
sign
would
indic
toxic
unpublish
data
suggest
inhibitori
level
achiev
vivo
current
determin
whether
gramedi
replic
inhibit
vitro
translat
attenu
viru
replic
mous
model
rotaviru
infect
monkey
kidney
epitheli
cell
atcc
maintain
dulbecco
modifi
eagl
medium
dmem
mediatech
supplement
fetal
bovin
serum
fb
atlanta
biolog
rhesu
rotaviru
strain
rrv
propag
cell
stock
titer
determin
immunofluoresc
focu
assay
ifa
see
glycyrrhizin
ga
acid
gra
purchas
sigmaaldrich
stock
solut
prepar
concentr
mgml
dmso
aliquot
store
stock
solut
dilut
work
concentr
dmem
without
fb
cell
viabil
condit
ga
gra
treatment
measur
celltiterglo
luminesc
cell
viabil
assay
promega
follow
manufactur
protocol
control
cell
viabil
toxic
consist
cell
media
alon
treatment
digitonin
respect
rotaviru
infect
follow
variou
treatment
determin
ifa
previous
describ
briefli
cell
cultur
confluenc
microtit
plate
well
inocul
dilut
rrv
stock
pretreat
tpcktrypsin
worthington
biochem
minut
sixteen
hour
postinfect
cell
fix
minut
paraformaldehyd
minut
ice
cold
methanol
permeabil
membran
structur
protein
detect
mous
monoclon
antibodi
dilut
follow
alexa
fluor
w
goat
antimous
antibodi
molecular
probe
foci
indic
infect
cell
enumer
titer
express
fluoresc
focu
unit
ffu
per
ml
infect
perform
previous
describ
cell
inocul
trypsinactiv
rrv
multipl
infect
three
pfucel
viru
adsorb
cell
one
hour
follow
adsorpt
step
media
remov
replac
fresh
media
without
compound
accord
paramet
experi
six
hour
postinfect
cell
supernat
collect
subject
three
freezethaw
cycl
lysat
clarifi
low
speed
centrifug
viru
supernat
titer
ifa
ga
gra
dmso
vehicl
control
ad
cultur
time
indic
experi
preinfect
treatment
six
hour
prior
addit
viru
compound
present
media
remaind
infect
postinfect
treatment
compound
ad
follow
viru
adsorpt
entri
step
present
media
durat
infect
cell
lysat
immunoblot
prepar
previous
describ
protein
separ
sdspolyacrylamid
gel
electrophoresi
immunoblot
probe
rotaviru
polyclon
antiserum
recogn
structur
protein
antigapdh
ambion
kindli
provid
est
baylor
colleg
medicin
antibodi
protein
react
antibodi
visual
chemiluminesc
use
pierc
ecl
kit
